2019 Von Hippel-Lindau Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

February 2019 | 36 pages | ID: 20668874497EN
VPAResearch

Abstracts

The ongoing clinical trial research report- “2019 Von Hippel-Lindau Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Von Hippel-Lindau Syndrome trials across the world. The report presents top level analysis of global Von Hippel-Lindau Syndrome clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Von Hippel-Lindau Syndrome trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Von Hippel-Lindau Syndrome clinical trials by-

• Region (Asia Pacific, Europe, Middle East Africa and Americas)
• Countries
• Trial Phase
• Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
• Type of the trial (Interventional, Observational)
• Sponsor Type (Companies, Universities, Government Bodies etc)
• Enrollment across types, sponsor types, geographies, current status and phases

The report also identifies the potential drug candidates under development for treatment of Von Hippel-Lindau Syndrome on the basis of intervention type ongoing Von Hippel-Lindau Syndrome trials.

The research work is prepared through extensive and continuous research on Von Hippel-Lindau Syndrome trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

REPORT SCOPE AND COVERAGE:

• All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Von Hippel-Lindau Syndrome patients are identified
• The report includes panorama of ongoing Von Hippel-Lindau Syndrome clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Von Hippel-Lindau Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Von Hippel-Lindau Syndrome Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
  2.2.1 Ongoing Von Hippel-Lindau Syndrome Clinical Trials by Region
  2.2.2 Average Enrollment of Von Hippel-Lindau Syndrome Clinical Trials
  2.2.3 Companies participating in Ongoing Trials
  2.2.4 Drugs under Study for Von Hippel-Lindau Syndrome Treatment, 2019

3. REGION WISE VON HIPPEL-LINDAU SYNDROME CLINICAL TRIALS

3.1 Asia Pacific Von Hippel-Lindau Syndrome Clinical Trials by Country
3.2 Europe Von Hippel-Lindau Syndrome Clinical Trials by Country
3.3 North America Von Hippel-Lindau Syndrome Clinical Trials by Country
3.4 Middle East and Africa Von Hippel-Lindau Syndrome Clinical Trials by Country
3.5 South and Central America Von Hippel-Lindau Syndrome Clinical Trials by Country

4. VON HIPPEL-LINDAU SYNDROME CLINICAL TRIAL TRENDS

4.1 Start Year wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials
4.2 Phase wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials
4.3 Trial Status wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials
4.4 Trial Type wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials

5. VON HIPPEL-LINDAU SYNDROME AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Von Hippel-Lindau Syndrome Trials by Year
5.2 Average Enrollment in Von Hippel-Lindau Syndrome Trials by Phase
5.3 Average Enrollment in Von Hippel-Lindau Syndrome Trials by Status
5.4 Average Enrollment in Von Hippel-Lindau Syndrome Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONGOING VON HIPPEL-LINDAU SYNDROME CLINICAL TRIALS

6.1 Ongoing Von Hippel-Lindau Syndrome Trials by Sponsor Type
6.2 Von Hippel-Lindau Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ongoing Von Hippel-Lindau Syndrome Trials- Phase
7.2 Ongoing Von Hippel-Lindau Syndrome Trials- Phase
7.3 Ongoing Von Hippel-Lindau Syndrome Trials- Phase
7.4 Ongoing Von Hippel-Lindau Syndrome Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Von Hippel-Lindau Syndrome Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Figure 9: Von Hippel-Lindau Syndrome Ongoing Clinical Trials by Phase
Figure 10: Von Hippel-Lindau Syndrome Ongoing Clinical Trials by Trial Status
Figure 11: Von Hippel-Lindau Syndrome Ongoing Clinical Trials by Type
Figure 12: Von Hippel-Lindau Syndrome Ongoing Clinical Trials by Sponsor Type
Figure 13: Von Hippel-Lindau Syndrome Ongoing Clinical Trials by Leading Sponsors
Figure 14: Von Hippel-Lindau Syndrome Average Enrollment by Phase
Figure 15: Von Hippel-Lindau Syndrome Average Enrollment by Trial Status
Figure 16: Von Hippel-Lindau Syndrome Average Enrollment by Type
Figure 17: Von Hippel-Lindau Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Von Hippel-Lindau Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Von Hippel-Lindau Syndrome Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Von Hippel-Lindau Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Von Hippel-Lindau Syndrome Average Enrollment by Phase
Table 15: Von Hippel-Lindau Syndrome Average Enrollment by Trial Status
Table 16: Von Hippel-Lindau Syndrome Average Enrollment by Type
Table 17: Von Hippel-Lindau Syndrome- Average Enrolment by Type of Sponsors
Table 18: Von Hippel-Lindau Syndrome- Enrolment by Leading Sponsors